Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $589.0 million.

  • Chemours' Accumulated Expenses rose 3176.73% to $589.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $589.0 million, marking a year-over-year increase of 3176.73%. This contributed to the annual value of $393.0 million for FY2024, which is 6285.44% down from last year.
  • As of Q3 2025, Chemours' Accumulated Expenses stood at $589.0 million, which was up 3176.73% from $608.0 million recorded in Q2 2025.
  • Over the past 5 years, Chemours' Accumulated Expenses peaked at $1.1 billion during Q4 2023, and registered a low of $263.0 million during Q2 2022.
  • Over the past 5 years, Chemours' median Accumulated Expenses value was $393.0 million (recorded in 2024), while the average stood at $519.3 million.
  • Per our database at Business Quant, Chemours' Accumulated Expenses soared by 25361.22% in 2023 and then plummeted by 6285.44% in 2024.
  • Quarter analysis of 5 years shows Chemours' Accumulated Expenses stood at $325.0 million in 2021, then fell by 7.69% to $300.0 million in 2022, then skyrocketed by 252.67% to $1.1 billion in 2023, then plummeted by 62.85% to $393.0 million in 2024, then skyrocketed by 49.87% to $589.0 million in 2025.
  • Its Accumulated Expenses stands at $589.0 million for Q3 2025, versus $608.0 million for Q2 2025 and $401.0 million for Q1 2025.